Oruka Therapeutics, Inc. short interest in 2022
In 2022, Oruka Therapeutics, Inc.'s disclosed short interest ran from 2.26% of shares outstanding on 14 Jan 2022 to 0.36% on 15 Dec 2022, a change of -1.90 percentage points. The year's high was 2.26% on 14 Jan 2022 and its low 0.35% on 31 Oct 2022, averaging 1.04% across 23 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 4.39 days on 15 Feb 2022. Full history: Oruka Therapeutics, Inc..
Cite this page
By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2022 in figures
- Start of year
- 2.26% (14 Jan 2022)
- End of year
- 0.36% (15 Dec 2022)
- Change
- -1.90 pp
- High
- 2.26% (14 Jan 2022)
- Low
- 0.35% (31 Oct 2022)
- Average
- 1.04%
- Highest days to cover
- 4.39 (15 Feb 2022)
- SEC filings marked
- 8
Every report in 2022
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 14 Jan 2022 | 2.26% | 1.83 | |
| 31 Jan 2022 | 2.23% | 2.46 | |
| 15 Feb 2022 | 2.09% | 4.39 | |
| 28 Feb 2022 | 1.92% | 2.57 | |
| 15 Mar 2022 | 1.62% | 1.87 | 10-K filed, results (8-K) |
| 31 Mar 2022 | 1.97% | 1.13 | |
| 14 Apr 2022 | 1.60% | 1.00 | |
| 29 Apr 2022 | 1.53% | 1.67 | |
| 13 May 2022 | 1.41% | 2.02 | 10-Q filed, results (8-K) |
| 31 May 2022 | 1.16% | 2.93 | |
| 15 Jun 2022 | 0.99% | 4.06 | |
| 30 Jun 2022 | 0.73% | 1.82 | |
| 15 Jul 2022 | 0.50% | 1.87 | |
| 29 Jul 2022 | 0.40% | 1.58 | |
| 15 Aug 2022 | 0.39% | 1.64 | 10-Q filed, results (8-K) |
| 31 Aug 2022 | 0.37% | 1.67 | |
| 15 Sep 2022 | 0.55% | 1.97 | |
| 30 Sep 2022 | 0.40% | 1.38 | |
| 14 Oct 2022 | 0.39% | 2.89 | |
| 31 Oct 2022 | 0.35% | 2.36 | 10-Q filed, results (8-K) |
| 15 Nov 2022 | 0.35% | 2.27 | |
| 30 Nov 2022 | 0.37% | 2.65 | |
| 15 Dec 2022 | 0.36% | 1.71 |
See also: Oruka Therapeutics, Inc.'s full history · most shorted US stocks of 2022 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.